# OnCo record paper-ciltacabtagene-autoleucel-multiple-myeloma-front-immunol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ciltacabtagene-autoleucel-multiple-myeloma-front-immunol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ciltacabtagene-autoleucel-multiple-myeloma-front-immunol-2022" ;
  schema:name "Ciltacabtagene autoleucel: The second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma"@en ;
  schema:description "Review on Ciltacabtagene autoleucel in Multiple myeloma, in Frontiers in immunology (2022), one of the most cited Europe PMC records with Ciltacabtagene autoleucel in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-ciltacabtagene-autoleucel-multiple-myeloma-front-immunol-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fimmu.2022.991092>, <https://pubmed.ncbi.nlm.nih.gov/36119032/>, <https://europepmc.org/article/MED/36119032> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.3389/fimmu.2022.991092> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Chekol Abebe E, Yibeltal Shiferaw M, Tadele Admasu F, et al." .